Literature DB >> 6175161

Ataxia-telangiectasia: immunocytochemical demonstration of alpha-fetoprotein and hepatitis B surface antigen in the liver.

E Ohama, F Ikuta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175161     DOI: 10.1007/BF00691176

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  10 in total

1.  Immunoperoxidase localisation of hepatitis B antigen (HB) in formalin-paraffin processed liver tissue.

Authors:  J Burns
Journal:  Histochemistry       Date:  1975-07-30

2.  ATAXIA-TELANGIECTASIA. ITS ASSOCIATION WITH A DEFECTIVE THYMUS, IMMUNOLOGICAL-DEFICIENCY DISEASE, AND MALIGNANCY.

Authors:  R D PETERSON; W D KELLY; R A GOOD
Journal:  Lancet       Date:  1964-05-30       Impact factor: 79.321

Review 3.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

4.  Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies.

Authors:  T Shikata; T Uzawa; N Yoshiwara; T Akatsuka; S Yamazaki
Journal:  Jpn J Exp Med       Date:  1974-02

5.  Serum-alpha-fetoprotein levels in patients with ataxia-telangiectasia.

Authors:  T A Waldmann; K R McIntire
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

6.  Ataxia-telangiectasia.

Authors:  D E McFarlin; W Strober; T A Waldmann
Journal:  Medicine (Baltimore)       Date:  1972-07       Impact factor: 1.889

7.  Background staining and sensitivity of the unlabelled antibody-enzyme (PAP) method. Comparison with the peroxidase labelled antibody sandwich method using formalin fixed paraffin embedded material.

Authors:  J Burns
Journal:  Histochemistry       Date:  1975-06-05

8.  Lymphoid tissue abnormalities associated with ataxia-telangiectasia.

Authors:  R D Peterson; M D Cooper; R A Good
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

9.  Alphafetoprotein levels of liver cancer patients and controls in a European population.

Authors:  D Trichopoulos; P Sizaret; E Tabor; R J Gerety; N Martel; N Munoz; G Theodoropoulos
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Hepatitis B and primary hepatocellular carcinoma in a European population.

Authors:  D Trichopoulos; E Tabor; R J Gerety; E Xirouchaki; L Sparros; N Munoz; C A Linsell
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.